Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Anaptysbio (ANAB) Debt to Equity (2016 - 2018)

Anaptysbio's Debt to Equity history spans 3 years, with the latest figure at $0.0 for Q4 2018.

  • For Q4 2018, Debt to Equity fell 94.77% year-over-year to $0.0; the TTM value through Dec 2018 reached $0.0, down 94.77%, while the annual FY2018 figure was $0.0, 94.77% down from the prior year.
  • Debt to Equity reached $0.0 in Q4 2018 per ANAB's latest filing, down from $0.0 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $0.12 in Q1 2017 to a low of -$0.36 in Q4 2016.
  • Average Debt to Equity over 3 years is $0.0, with a median of $0.02 recorded in 2018.
  • Peak YoY movement for Debt to Equity: skyrocketed 106.8% in 2017, then tumbled 94.77% in 2018.
  • A 3-year view of Debt to Equity shows it stood at -$0.36 in 2016, then surged by 106.8% to $0.02 in 2017, then tumbled by 94.77% to $0.0 in 2018.
  • Per Business Quant, the three most recent readings for ANAB's Debt to Equity are $0.0 (Q4 2018), $0.0 (Q3 2018), and $0.01 (Q2 2018).